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Abstract
Background—Congenital diaphragmatic hernia (CDH) remains a significant cause of death in
newborns. With advances in neonatal critical care and ventilation strategies, survival in the term
infant now exceeds 80% in some centers. Although prematurity is a significant risk factor for
morbidity and mortality in most neonatal diseases, its associated risk with infants with CDH has
been described poorly. We sought to determine the impact of prematurity on survival using data
from the Congenital Diaphragmatic Hernia Registry (CDHR).
Methods—Prospectively collected data from live-born infants with CDH were analyzed from the
CDHR from January 1995 to July 2009. Preterm infants were defined as <37 weeks estimated
gestational age at birth. Univariate and multivariate logistic regression analysis were performed.
Results—During the study period, 5,069 infants with CDH were entered in the registry. Of the
5,022 infants with gestational age data, there were 3,895 term infants (77.6%) and 1,127 preterm
infants (22.4%). Overall survival was 68.7%. A higher percentage of term infants were treated
with extracorporeal membrane oxygenation (ECMO) (33% term vs 25.6% preterm). Preterm
infants had a greater percentage of chromosomal abnormalities (4% term vs 8.1% preterm) and
major cardiac anomalies (6.1% term vs 11.8% preterm). Also, a significantly higher percentage of
term infants had repair of the hernia (86.3% term vs 69.4% preterm). Survival for infants that
underwent repair was high in both groups (84.6% term vs 77.2% preterm). Survival decreased
with decreasing gestational age (73.1% term vs 53.5% preterm). The odds ratio (OR) for death
among preterm infants adjusted for patch repair, ECMO, chromosomal abnormalities, and major
cardiac anomalies was OR 1.68 (95% confidence interval [CI], 1.34–2.11).
Conclusion—Although outcomes for preterm infants are clearly worse than in the term infant,
more than 50% of preterm infants still survived. Preterm infants with CDH remain a high-risk
group. Although ECMO may be of limited value in the extremely premature infant with CDH,
most preterm infants that live to undergo repair will survive. Prematurity should not be an
independent factor in the treatment strategies of infants with CDH.
Survival for neonates born with congenital diaphragmatic hernia CDH has been
demonstrated to range from 60% to 90% based on hospital data for survival to discharge.1–3
Overall, survival has improved significantly during the last 30 years and is consistently
reported around 65% for all infants.2 However, institutional outcomes still remain highly
variable.4–6 These center differences have been attributed to heterogeneity in disease
severity and variability in therapeutic strategies among institutions. However, with advances
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in the management of neonatal respiratory failure including extracorporeal membrane
oxygenation (ECMO) and ventilator strategies, survival has improved. As a result, high-risk
CDH patients including premature infants are being treated.
Prematurity is the strongest influence on poor outcomes for all neonatal diseases.7 The
overall premature birth rate was 12.8% in 2006, which includes a higher proportion in
children with CDH.8–10 Levison et al11 found a 30% incidence of prematurity in infants with
CDH with a nearly 50% decrease in survival, compared with term infants with CDH (35%
vs 64%, respectively; unadjusted odds ratio [OR], 3.45; 95% confidence interval [CI], 1.83–
6.50).11 However, it remains unclear whether this decrease in survival is solely attributed to
the CDH or other associated factors such as gestational age at delivery.
The purpose of this study was to evaluate infants born with CDH from a large international,
multi-center registry. Term and preterm infants were compared with regard to overall
survival.
METHODS
Data
The Congenital Diaphragmatic Hernia Study Group (CDHSG) was formed in 1995 to
compile data on live-born neonates with CDH to allow assessment of therapies and
outcome. Data are collected on all inborn or transferred infants with CDH to form the
Congenital Diaphragmatic Hernia Registry (CDHR). The CDHSG is a voluntary
collaboration of international tertiary referral centers providing care for CDH patients who
provide data to a central registry (participating centers specified in the appendix). The
CDHSG registry was approved by the University of Texas School of Medicine at Houston
Institutional Review Board (HSC-MS-03-223).
Participating centers filed a waiver of consent for data submission or signed a data use
agreement for a limited data set. Data include information on delivery and subsequent
hospitalization until death or discharge. Because of the registry nature of the data, patients in
the CDHR may not have complete data for all variables.
The current study used prospectively collected data from the CDHR from January 1995 to
July 2009 from 98 international institutions. Preterm infants were defined as <37 weeks
estimated gestational age (GA) at birth. Infants were categorized to preterm and term status
with subgrouping of prematurity at 35–36 weeks GA, 33–34 weeks GA, 31–32 weeks GA,
29–30 weeks GA, and ≤28 weeks GA. Patient demographics, birth weight, GA, Apgar
scores, associated anomalies, defect size, need for ECMO, treatment details (including
surgical timing/approach, need for patch, ventilator management, survival, morbidity (such
as gastroesophageal reflux disease, feeding approach, and need for oxygen at 30 days), and
duration of stay were collected. Survival was defined as alive at hospital discharge or
transfer. Significant associated anomalies included cardiac defects, chromosomal anomalies,
and syndromes. Major cardiac anomalies were defined as all cardiac anomalies except patent
ductus arteriosus, isolated atrial septal defect, and isolated ventricular septal defects.
Statistical analysis
Clinical variables including death before hospital discharge are reported as percentages and
means ± standard deviation. Term and preterm proportions were compared using Chi square
analysis with P < .05 was considered statistically significant. Logistic regression was used to
evaluate association among variables and death before hospital discharge adjusting for
prematurity. Odds ratios were calculated and 95% CIs were generated. The analysis was
conducted using STATA 10 (Stata Corp., College Station, TX).
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A univariable analysis was performed initially to evaluate the association of each predictor
variable with the primary outcome of survival. All independent variables were analyzed,
which included patient demographics, status at delivery, treatment and operative data, and
associated comorbidities. Statistically significant variables were used in a multivariable
logistic regression analysis. These variables were evaluated for their influence on the
primary outcome independently as well as in combination for interaction and confounding.
RESULTS
In all, 5,069 live-born infants with CDH were identified from the CDHR. GA data were
available in 5,022 patients. Also included were 3,895 term infants (77.6%) and 1,127
preterm infants (22.4%). Most defects were left-sided (81.5%) with 1% bilateral lesions.
Preterm infants had a higher percentage of chromosomal anomalies (8.1% vs 4.0%; P < .
0001) and major cardiac defects (11.8% vs 6.1%; P < .0001). Descriptive statistics for all
variables are shown in Table I.
ECMO
Overall, 1,577 infants (31.3%) with CDH underwent ECMO. This included patients who
were repaired before, after, or on ECMO as well as nonrepaired infants. ECMO use was less
as GA decreased. However, 8 infants (3.7%) at ≤32 weeks GA underwent ECMO with an
average birth weight of 2.3 kg. Six of these infants underwent repair and survived. None had
chromosomal or major cardiac anomalies.
CDH repair
Repair data were available in 5,028 infants. All repair types were included. Overall, 82.6%
of patients underwent repair including 86.3% for term infants. However, the percentage of
infants who underwent operative repair decreased significantly with decreasing GA (Table
II). Preterm infants had a significantly lower repair rate (69.4%; P < .001).
Data on primary repair or need for patch were available in 4,112 infants. Primary repair was
performed in 2,125 patients (51.7%). Preterm infants had a significantly higher rate of patch
repairs (57.9% preterm vs 46.1% term; P < .05).
Survival
The overall survival for the entire study cohort was 68.7%. Term infants had a significantly
higher survival at 73.1% compared with preterm infants at 53.5% (P < .001). As expected,
the overall survival rate decreased with decreasing GA (Fig). For infants who underwent
repair, overall survival was 83.2%. Although the overall survival was higher in those who
underwent repair, pre-term infants who underwent repair still had a significantly lower rate
of survival (77.2% vs 84.6%; P < .0001).
All patient variables were evaluated for association with death using univariate analysis.
Prematurity, chromosomal anomalies, major cardiac defects, need for patch repair, and need
for ECMO were identified as variables that highly correlated with mortality. A multiple
logistic regression analysis was performed with these significant variables. The independent,
unadjusted odds of death included the following: prematurity (OR, 2.36; 95% CI, 2.06–
2.71), chromosomal anomalies (OR, 5.68; 95% CI, 4.28–7.52), major cardiac anomalies
(OR, 1.99; 95% CI, 1.80–2.20), patch repair (OR, 9.02; 95% CI, 7.20–11.30), and need for
ECMO (OR, 3.13; 95% CI, 2.76–3.55). The adjusted OR for death among preterm infants
was 1.68 (95% CI, 1.34–2.11).
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DISCUSSION
Despite advances in neonatal critical care, prematurity remains a significant contributor to
neonatal mortality in infants with CDH. The incidence of prematurity has increased in the
last decade and remains a major cause of mortality in all neonates.12 Although the severity
of pulmonary hypoplasia and hypertension are the major determinants of overall survival for
infants with CDH, some mortality may be attributed to prematurity because of an increase in
associated anomalies. Ninety-five percent of stillborn infants with CDH have an additional
major anomaly.13 The impact of prematurity and associated major anomalies on survival
among infants with CDH has been described. Compared with those with non–hernia-related
anomalies, infants with isolated CDH have a significant survival advantage.14 More than
60% of infants who do not survive the immediate neonatal period have associated
anomalies.15 Consequently, successfully managed infants who survive preoperative
stabilization and undergo operative repair have less than 10% occurrence of additional
anomalies.15
Overall, this study demonstrated 53.5% survival in preterm infants. Although survival
decreased with younger gestational ages, infants born after 31 weeks GA still had a survival
rate greater than 40%. In general, specific factors that influence mortality remain difficult to
delineate, and outcome studies are difficult to interpret because of the tremendous variations
in patient disease, management strategies, and operative techniques. Each institution (and
even surgeon) is somewhat individualized and maintains certain management preferences,
which include ventilation strategies, availability and entry criteria for ECMO, and
indications for operative timing. In effort to delineate the impact of prematurity, this study
identified significant associated factors that may influence survival including need for
ECMO, associated major cardiac anomalies, and chromosomal abnormalities. The analysis
demonstrated that prematurity had an increased OR 1.68 (95% CI, 1.34–2.11) for death after
adjusting for those significant factors.
A critical factor that influences overall survival is the severity of pulmonary hypoplasia and
hypertension. Unfortunately, the CDHR did not start investigating and collecting data with
regard to pulmonary hypertension until its third version, which began in January 2007. As a
result, these parameters were incomplete for the entire cohort in this study and could not be
analyzed specifically. As a surrogate, repair type (either primary repair or patch repair) was
used as marker for disease severity. Infants who can undergo a primary repair typically have
small defects with mild to minimal pulmonary limitations. Infants with larger defects, such
as diaphragmatic agenesis, will invariably be critically ill and require advance therapies such
as ECMO. In our cohort, preterm infants had a significant increased rate of patch repair
(57.9% preterm vs 46.1% term) with an adjusted OR 9.02 (95% CI, 7.20–11.30) for death.
Important limitations of this study lie in the nature of registry data. As with all outcome
studies of CDH, data from the CHDR must be used with caution. A tremendous
heterogeneity of disease severity exists within institutions and a wide spectrum of
institutions within the CDHSG. As a result, centers may still be limited in their experience
with rare, high-risk patients such as preterm infants with major associated anomalies despite
being considered a high-volume center. Moderate-risk patients who are repaired at one
institution may be considered high risk at another and not be operative candidates. As such,
comparison of outcomes among centers should be stratified by disease severity. In our study,
the need for patch repair served as a reflection of pulmonary hypertension and hypoplasia
severity.
Regardless, the CDHR is a vehicle to collect data from a large number of patients on a rare
condition. Such large international registries offer some advantages by ameliorating some
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institutional biases in patient selection and treatment effects. Registry data remain useful to
address broad questions with definable answers. The translation to specific clinical
guidelines must be done with caution. Each institution should still recognize their
therapeutic limitations. However, even though survival of preterm infants born with CDH is
lower as their term counterparts, overall survival is still greater than 50%, with
approximately 31% survival of the very preterm infants (≤28 weeks estimated GA). Their
high rate of associated anomalies is likely responsible, at least in part, for this increased
mortality. Because many of these patients may not be candidates for ECMO based on size
alone, survival depends on disease severity, comorbidities, and efficacy of other therapeutic
interventions. After adjusting for these factors, preterm infants still have increased odds of
death. As a result, prematurity in infants with CDH should not be used a sole parameter to
determine initiation of therapy.
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Figure.
Overall CDH survival by GA.
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Appendix
Members of the CDHSG registry
Hospital City, state/province Country
Arkansas Children’s Hospital Little Rock, AR
Astrid Lindgren Children’s Hospital Stockholm Sweden
BC Children’s & Women’s Health Centre Vancouver, British Columbia Canada
Cardinal Glennon Children’s Hospital St. Louis, MO
Levine Children’s Hospital Charlotte, NC
Cedars Sinai Medical Center Los Angeles, CA
Central Hospital Aichi Prefectural Colony Kasugai Aichi Japan
Children’s Hospital Medical Center Boston, MA
Children’s Hospital of Akron Akron, OH
Children’s Hospital of Austin Austin, TX
Children’s Hospital of Buffalo Buffalo, NY
Children’s Hospital of Illinois Peoria, IL
Children’s Hospital of Los Angeles Los Angeles, CA
Children’s Hospital of Michigan Detroit, MI
Children’s Hospital of Oakland Oakland, CA
Children’s Hospital of Oklahoma Oklahoma City, OK
Children’s Hospital of Philadelphia Philadelphia, PA
Children’s Hospital of Wisconsin Milwaukee, WI
Children’s Hospital Omaha Omaha, NE
Children’s Hospitals and Clinics Minneapolis, MN
Children’s Memorial Hermann Hospital Houston, TX
Children’s Mercy Hospitals & Clinics Overland Park, KS
Children’s National Medical Center Washington, DC
Cincinnati Children’s Hospital Medical Center Cincinnati, OH
Cleveland Clinic Foundation-Children’s Hospital Cleveland, OH
Cook Children’s Medical Center Ft. Worth, TX
Duke University Medical Center Durham, NC
Emory University Atlanta, GA
Freie Universitat Berlin Berlin Germany
Golisano Children’s Hospital at Strong Rochester, NY
Hasbro Children’s Hospital Providence, RI
Helen DeVos Children’s Hospital Grand Rapids, MI
Hershey Medical Center Hershey, PA
James Whitcomb Riley Children’s Hospital Indianapolis, IN
Kosair Children’s Hospital Louisville, KY
Le Bonheur Children’s Medical Center Memphis, TN
Legacy Emanuel Children’s Hospital Portland, OR
Loma Linda University Children’s Hospital Loma Linda, CA
Lucile Salter Packard Children’s Hospital Palo Alto, CA
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Hospital City, state/province Country
Lutheran General Hospital Park Ridge, IL
Massachusetts General Hospital Boston, MA
Mattel Children’s Hospital at UCLA Los Angeles, CA
Mayo Clinic Rochester, MN
Medical College of Georgia Augusta, GA
Medical College of Virginia Richmond, VA
Medical University of South Carolina Charleston, SC
Miami Valley Hospital Dayton, OH
National Center for Child Health and Development Tokyo Japan
North Carolina Baptist Hospital Winston-Salem, NC
Oespedale Pediatrico Bambino Gesu Rome Italy
Oespedale Riuniti Bergamo Bergamo Italy
Osaka Medical Center for Maternal and Child Health Osaka Japan
Osaka University Graduate School of Medicine Osaka Japan
Phoenix Children’s Hospital Phoenix, AZ
Primary Children’s Hospital Salt Lake City, UT
Radboud University Nijmegen Medical Centre Nijmegen The Netherlands
Rainbow Babies and Children Hospital Cleveland, OH
Rockford Memorial Children’s Hospital Rockford, IL
Royal Alexandra Hospital Edmonton, Alberta Canada
Royal Children’s Hospital Parkville Victoria Australia
Royal Hospital for Sick Children Glasgow Scotland
Salesi Children’s Hospital Ancona Italy
San Diego Children’s Hospital San Diego, CA
Santa Rosa Children’s Hospital San Antonio, TX
Shands Children’s Hospital/University of Florida Gainesville, FL
Sophia Children’s Hospital Rotterdam The Netherlands
St. Christopher’s Children’s Hospital Philadelphia, PA
St. Francis Children’s Hospital Tulsa, OK
St. Joseph’s Hospital and Medical Center Phoenix, AZ
St. Louis Children’s Hospital St. Louis, MO
St. Paul Campus Children’s Minneapolis Minneapolis, MN
Stollery Children’s Hospital Edmonton, Alberta Canada
Sydney Children’s Hospital Randwick, New South Wales Australia
T.C. Thompson Hospital Chattanooga, TN
Texas Children’s Hospital Houston, TX
The Children’s Hospital of Alabama Birmingham, AL
The Hospital for Sick Children Toronto, Ontario Canada
Nationwide Children’s Hospital Columbus OH
Tulane University Hospital New Orleans, LA
Universitatsklinikum Mannheim Mannheim Germany
University Hospital Gasthuisberg Leuven Belgium
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Hospital City, state/province Country
University of California San Diego San Diego, CA
University of Chicago Chicago, IL
University of Kentucky Medical Center Lexington, KY
C.S. Mott Children’s Hospital Ann Arbor, MI
University of Mississippi Medical Center Jackson, MS
University of Nebraska Medical Center Omaha, NE
University of New Mexico Children’s Hospital Albuquerque, NM
University of North Carolina Chapel Hill, NC
University of Padua Padua Italy
University of Puerto Rico Medical Center San Juan Puerto Rico
University of Texas Medical Branch at Galveston Galveston, TX
University of Virginia Medical School Charlottesville, VA
Vanderbilt Children’s Hospital Nashville, TN
Wilford Hall USAF Medical Center Lackland AFB, TX
Winnie Palmer Hospital for Women & Babies Orlando, FL
Yale New Haven Children’s Hospital New Haven, CT
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